Skip to main content
Log in

Successful resection of a huge hepatocellular adenoma

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Hepatocellular adenoma (HCA) is a rare benign liver tumor that has been reported to occur particularly more often in women who use contraceptives. A 72-year-old woman with no history of using contraceptives presented to our hospital for further examination of a liver tumor. Contrast-enhanced computed tomography and gadoxetic acid-enhanced magnetic resonance imaging revealed a huge solitary hepatic tumor measuring 83 × 76 mm in segments 4, 5, and 8. The differential diagnoses were cholangiocarcinoma and mixed-type hepatocellular carcinoma. Percutaneous needle biopsies were performed twice, and no malignant components were found. Central bi-segmentectomy of the liver was successfully performed. Immunohistochemical staining showed that β-catenin was positive in the membrane of the tumor cells, while fatty acid-binding protein, glutamine synthetase, and amyloid A were negative. These results led to a diagnosis of HCA, hepatocyte nuclear factor-1α-inactivated subtype. The patient’s postoperative course was uneventful, and she developed no recurrence for 10 months after surgery. We experienced a rare case of benign HCA. Obtaining a correct preoperative diagnosis is sometimes difficult at the first evaluation. HCA should be considered as a differential diagnosis of liver tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of data and materials

Not applicable.

Abbreviations

HCA:

Hepatocellular adenoma

HNF-1α:

Hepatocyte nuclear factor-1α

CE-CT:

Contrast-enhanced computed tomography

MRI:

Magnetic resonance imaging

References

  1. Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644–8.

    Article  CAS  Google Scholar 

  2. Reddy KR, Schiff ER. Approach to a liver mass. Seminars Liver Dis. 1993;13:423–35.

    Article  CAS  Google Scholar 

  3. Sasaki M, Nakanuma Y. Overview of hepatocellular adenoma in Japan. Int J Hepatol. 2012;2012:648131.

    PubMed  PubMed Central  Google Scholar 

  4. Stoot JH, van der Linden E, Terpstra OT, et al. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg. 2007;94:1249–53.

    Article  CAS  Google Scholar 

  5. Terkivatan T, de Wilt JH, de Man RA, et al. Treatment of ruptured hepatocellular adenoma. Br J Surg. 2001;88:207–9.

    Article  CAS  Google Scholar 

  6. Chuang WY, Chen TC, Hsu HL, et al. Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases. J Formos Med Assoc. 2002;101:798–802.

    PubMed  Google Scholar 

  7. Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698–705.

    Article  Google Scholar 

  8. Micchelli ST, Vivekanandan P, Boitnott JK, et al. Malignant transformation of hepatic adenomas. Mod Pathol. 2008;21:491–7.

    Article  CAS  Google Scholar 

  9. Laurent A, Dokmak S, Nault JC, et al. European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group. HPB (Oxford). 2016;18:748–55.

    Article  Google Scholar 

  10. Bioulac-Sage P, Taouji S, Possenti L, et al. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32:1217–21.

    Article  Google Scholar 

  11. Dokmak S, Belghiti J. Will weight loss become a future treatment of hepatocellular adenoma in obese patients? Liver Int. 2015;35:2228–32.

    Article  Google Scholar 

  12. Bunchorntavakul C, Bahirwani R, Drazek D, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther. 2011;34:664–74.

    Article  CAS  Google Scholar 

  13. Katabathina VS, Menias CO, Shanbhogue AK, et al. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31:1529–43.

    Article  Google Scholar 

  14. Mounajjed T. Hepatocellular adenoma and focal nodular hyperplasia. Clin Liver Dis (Hoboken). 2021;17:244–8.

    Article  Google Scholar 

  15. Stoot JH, Coelen RJ, De Jong MC, et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509–22.

    Article  Google Scholar 

  16. Cho SW, Marsh JW, Steel J, et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol. 2008;15:2795–803.

    Article  Google Scholar 

  17. Kudo M. Malignant transformation of hepatocellular adenoma: how frequently does it happen? Liver Cancer. 2015;4:1–5.

    Article  CAS  Google Scholar 

  18. Kim DH, Kim SU, Nam DH, et al. A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male. Korean J Intern Med. 2009;24:147–52.

    Article  Google Scholar 

  19. Khaoudy I, Rebibo L, Regimbeau JM. Is bariatric surgery a potential new treatment for large inflammatory hepatocellular adenomas in obese patients? Surg Obes Relat Dis. 2018;14:535–8.

    Article  Google Scholar 

  20. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.

    Article  Google Scholar 

  21. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg. 2010;27:39–45.

    Article  CAS  Google Scholar 

  22. Laumonier H, Bioulac-Sage P, Laurent C, et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48:808–18.

    Article  Google Scholar 

  23. Bioulac-Sage P, Cubel G, Taouji S, et al. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Am J Surg Pathol. 2012;36:1691–9.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all staff members involved in the patient’s care. We also thank Angela Morben, DVM, ELS, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

HT, KH, HI, DT, AG, SF, KO, JH, TW, and YK participated in the diagnosis and treatment of the patient and wrote the first draft of this manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hideo Tomihara.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the patient to publish this case report and any accompanying images.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (TIF 461 KB)

Supplementary file2 (TIF 445 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tomihara, H., Hashimoto, K., Ishikawa, H. et al. Successful resection of a huge hepatocellular adenoma. Clin J Gastroenterol 14, 1544–1549 (2021). https://doi.org/10.1007/s12328-021-01486-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-021-01486-4

Keywords

Navigation